23andMe appoint new Chief Science Officer and Head of Therapeutics.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
New collaboration between Foundation Medicine and H3 aims to develop precision cancer therapies.
23andMe and FDA make significant progress in direct-to-consumer testing.
Tel Aviv University researcher identifies novel genetic mutations through DNA sequencing of afflicted child and family.
UC Berkeley & UC San Francisco launch gene-editing initiative.
Merck join the SGC with multi-million dollar contribution. Merck have announced a contribution of C$7.5 million to the Structural Genomics Consortium (SGC), joining as a member organisation. The supported project focus on per-competitive research to develop small inhibitory molecules called chemical probes to study epigenetic mechanisms of regulation. In collaboration with leading clinical institutions in […]
The long battle over BRCA1 and BRCA2 patent infringement finally comes to an end.